Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Rebulla

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Transfusion|April 20, 2010
Platelet efficacy revisited?Paolo Rebulla
Transfusion|November 9, 2002
Cord blood banking 2002: 112,010 of 7,914,773 chancesPaolo Rebulla
Journal of Proteomics|August 15, 2012
From pH to MALDI-TOF: hundreds of spotted opportunities?Paolo Rebulla
Current Opinion in Hematology|October 24, 2002
Refractoriness to platelet transfusionPaolo Rebulla
Blood Transfusion = Trasfusione Del Sangue|May 11, 2017
A pathogen reduction clinical trial in retrospectPaolo Rebulla
Haematologica|February 16, 2005
A mini-review on platelet refractorinessPaolo Rebulla
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 2, 2010
Cord blood banking and transplantation in 2010Paolo Rebulla
British Journal of Haematology|July 16, 2019
The long and winding road to pathogen reduction of platelets, red blood cells and whole bloodPaolo Rebulla
Haematologica|November 5, 2002
Platelet transfusionElena Coluccio, Paolo Rebulla
International Journal of Cardiology|September 1, 2004
Cell therapy: an evolutionary development of transfusion medicinePaolo Rebulla, Rosaria Giordano
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Transfusion|April 20, 2010
Platelet efficacy revisited?Paolo Rebulla
Transfusion|November 9, 2002
Cord blood banking 2002: 112,010 of 7,914,773 chancesPaolo Rebulla
Journal of Proteomics|August 15, 2012
From pH to MALDI-TOF: hundreds of spotted opportunities?Paolo Rebulla
Current Opinion in Hematology|October 24, 2002
Refractoriness to platelet transfusionPaolo Rebulla
Blood Transfusion = Trasfusione Del Sangue|May 11, 2017
A pathogen reduction clinical trial in retrospectPaolo Rebulla
Haematologica|February 16, 2005
A mini-review on platelet refractorinessPaolo Rebulla
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 2, 2010
Cord blood banking and transplantation in 2010Paolo Rebulla
British Journal of Haematology|July 16, 2019
The long and winding road to pathogen reduction of platelets, red blood cells and whole bloodPaolo Rebulla
Haematologica|November 5, 2002
Platelet transfusionElena Coluccio, Paolo Rebulla
International Journal of Cardiology|September 1, 2004
Cell therapy: an evolutionary development of transfusion medicinePaolo Rebulla, Rosaria Giordano
Pageof 10